tiprankstipranks
Ars Pharmaceuticals, Inc. (SPRY)
NASDAQ:SPRY
US Market
Want to see SPRY full AI Analyst Report?

ARS Pharmaceuticals (SPRY) Blogger Opinions & Sentiment

568 Followers

Blogger Sentiment

Bullish: 70.00%
Sector Average
Bullish
SPRY Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
100% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

ARS Pharmaceuticals: Still A Buy As Neffy Access Improves
SeekingAlpha
ARS Pharmaceuticals: A Significant Upside Is Expected From neffy
SeekingAlpha
ARS Pharmaceuticals: 'Betting On The Come'
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of SPRY?
Seeking Alpha’s Myriam Alvarez has a Bullish Sentiment.
    What do Motley Fool contributors think of SPRY?
    Currently there's no blogger sentiment for SPRY.
    What Is SPRY’s Blogger Sentiment?
    SPRY’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for SPRY?
      The most recent blogger prediction for SPRY was made by Myriam Alvarez, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          SPHRFStarpharma Holdings Limited
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          NURPFNeuren Pharmaceuticals Limited
          CLVLFClinuvel Pharmaceuticals